Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

被引：0
|
作者：
Yu, Guangbo [1 ]
Zhang, Zigeng [2 ]
Eresen, Aydin [2 ,3 ]
Hou, Qiaoming [2 ]
Amirrad, Farideh [4 ]
Webster, Sha [4 ]
Nauli, Surya [4 ,5 ]
Yaghmai, Vahid [2 ,3 ]
Zhang, Zhuoli [1 ,2 ,3 ,6 ]
机构：
[1] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92617 USA
[2] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92868 USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92612 USA
[4] Chapman Univ, Harry & Diane Rinker Hlth Sci Campus, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA
[5] Univ Calif Irvine, Dept Med, Irvine, CA 92868 USA
[6] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92617 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 22期
基金：
美国国家卫生研究院;
关键词：
PDAC; immunotherapy; immune checkpoint inhibitors; radiomics; artificial intelligence; deep learning; machine learning; PD-1; BLOCKADE; ANTI-CTLA-4; IMMUNOTHERAPY; PD-1/PD-L1; GUIDELINES; CRITERIA; LIGANDS; TUMORS; TRIAL;
D O I：
10.3390/ijms252212038
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options. This review examines the challenges and potential of using immunotherapy to treat pancreatic cancer, highlighting the role of artificial intelligence (AI) as a promising tool to enhance early detection and monitor the effectiveness of these therapies. By synthesizing recent advancements and identifying gaps in the current research, this review aims to provide a comprehensive overview of how AI and immunotherapy can be integrated to develop more personalized and effective treatment strategies. The insights from this review may guide future research efforts and contribute to improving patient outcomes in pancreatic cancer management.
引用
收藏
页数：14
相关论文
共 50 条
  • [31] Diagnosis, monitoring, and management of adverse events from immune checkpoint inhibitor therapy
    Khan, O. F.
    Monzon, J.
    CURRENT ONCOLOGY, 2020, 27 : S43 - S50
  • [32] ANALYZING REGULATORY REQUIREMENTS IN THE DEVELOPMENT OF IMMUNE CHECKPOINT INHIBITORS USING ARTIFICIAL INTELLIGENCE
    Perumal, Krish
    Osmani, Amin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A399 - A400
  • [33] Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
    Pradhan, Anjan K.
    Bhoopathi, Praveen
    Maji, Santanu
    Kumar, Amit
    Guo, Chunqing
    Mannangatti, Padmanabhan
    Li, Jiong
    Wang, Xiang-Yang
    Sarkar, Devanand
    Emdad, Luni
    Das, Swadesh K.
    Fisher, Paul B.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy
    He, Mengying
    Yang, Tao
    Wang, Yuhan
    Wang, Mengyuan
    Chen, Xingye
    Ding, Dawei
    Zheng, Yiran
    Chen, Huabing
    ADVANCED HEALTHCARE MATERIALS, 2021, 10 (09)
  • [35] Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy
    Morse, Michael A.
    Hochster, Howard
    Al Benson
    ONCOLOGIST, 2020, 25 (01): : 33 - 45
  • [36] Immune checkpoint inhibitor combination therapy for gastric cancer: Research progress
    Song, Xiaoxu
    Qi, Weiwei
    Guo, Jing
    Sun, Libin
    Ding, Aiping
    Zhao, Guanghui
    Li, Hui
    Qiu, Wensheng
    Lv, Jing
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [37] Cutaneous toxicities in lung cancer patients on immune checkpoint inhibitor therapy
    Patel, Anisha B.
    Keiser, Monika
    Altan, Mehmet
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB14 - AB14
  • [38] Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
    Zou, Xue-lin
    Li, Xiao-bo
    Ke, Hua
    Zhang, Guang-yan
    Tang, Qing
    Yuan, Jiao
    Zhou, Chen-jiao
    Zhang, Ji-liang
    Zhang, Rui
    Chen, Wei-yong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] Ophthalmic complications of immune checkpoint inhibitor therapy for metastatic ovarian cancer
    Kiernan, Miles
    Zatorska, Anna
    Mau, Yen Ning
    Vahdani, Kaveh
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (06): : E194 - E194
  • [40] Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer
    Li, Na
    Wang, Geng
    Hou, Xin
    Tai, Risheng
    Huang, Shaogang
    He, Zhize
    Lei, Lei
    Xu, Suling
    Yang, Shanru
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
12345